Innovative Redevelopment of Shuanghuanglian
双黄连二次开发的示范研究

Shuanghuanglian (SHL),an essential Chinese patent medicine (CPM),has been used clinically to treat acute up- per respiratory infection (AURI) in China for more than 30 years.Along with the advancement of industrial pharmaceu- tics,it needs to upgrade the traditional SHL producing techniques,in an attempt to raise its therapeutic effects.This review discusses a range of improvements involving the redevelopment of the drug,including,superficial fluid extrac- tion,dispersible tablet preparation,fingerprint chr...